01 May 2006
Choosing incentives to stimulate tuberculosis treatment compliance in a poorcounty in Rio de Janeiro state, Brazil.
Marcia Teresa Carreira Teixeira Belo, Marcia Teresa Carreira Teixeira Belo, Ronir Raggio Luiz, Christy Hanson, Ana Lucia Luna, Ana Lucia Luna, Anete TrajmanMed Sci Monit 2006; 12(5): PH1-5 :: ID: 450296
Abstract
Background: Tuberculosis (TB) treatment default is a major constraint ofTB control, resulting in continued disease transmission and possibly the emergence of multidrug resistance.Marginalized populations may abandon treatment before being cured. The objective of this study was toevaluate the socioeconomic status (SES) of TB patients and identify potential incentives for improvingtreatment compliance by SES. Material/Methods: A cross-sectional survey was conducted in a public healthunit in Duque de Caxias, a county with one of the lowest per capita incomes in Rio de Janeiro state.From November 2003 to March 2004, 305 TB patients answered an anonymous questionnaire on socio-demographicaspects, household items and family income, history of previous treatment default, and on incentivesfor improving treatment adherence. Incentives were classified as economic, administrative, health servicesupport, and habits, and scored as fundamental (3), important (2), desirable (1), or irrelevant (0).Results: Health service support incentives had the highest scores overall. The aggregate economic incentivescore correlated with SES (r=-0.191, p=0.001). Among the 20% poorest patients, 16.7% had a previous historyof default vs. 1.6% among the wealthiest (p=0.004). Patients with a history of treatment default weresignificantly more likely to choose health service support incentives than other patients (r=-0.263,p=0.039). Conclusions: Professional commitment will be needed to effect the necessary changes in healthservice support. Financial support for food and transportation subsidies may be required to improve treatmentcompliance among the poorest TB patients, i.e. those most likely to have previously defaulted from treatment.
Keywords: Tuberculosis - drug therapy, Questionnaires, Public Health, Poverty, Patient Compliance, Motivation, Cross-Sectional Studies, Brazil, Antitubercular Agents - therapeutic use, Aged, 80 and over, Adolescent
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952